“Excessive Self-Restraint” of Promotion Activities by Drug Makers Hindering Drugs’ Lifecycle Management: Physician

Dr Masaaki Miyakawa Nearly a year has passed since the health ministry’s guidelines on ethical drug detailing activities went into effect in April last year. While drug makers have been careful to follow the guidelines in the wake of cases...read more